Sourcebio International logo

SBI - Sourcebio International Share Price

188p -2.0  -1.1%

Last Trade - 1:44pm

Sector
Healthcare
Size
Small Cap
Market Cap £140.9m
Enterprise Value £244.6m
Revenue £21.5m
Position in Universe 923rd / 1809
Bullish
Bearish
Unlock SBI Revenue
Momentum
Relative Strength (%)
1m -18.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 29.5 24.2 21.2 -15.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, SourcebioInternational PLC revenues increased 2% to £10.6M. Net lossincreased 6% to £4.2M. Revenues reflect Infectious DiseaseTesting segment increase from £0K to £2.2M. Higher net lossreflects Finance expense increase of 14% to £5M (expense),Administrative expenses increase of 3% to £3.1M (expense).Basic Earnings per Share excluding Extraordinary Itemsdecreased from -£0.05 to -£0.06.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SBI Revenue Unlock SBI Revenue

Net Income

SBI Net Income Unlock SBI Revenue

Normalised EPS

SBI Normalised EPS Unlock SBI Revenue

PE Ratio Range

SBI PE Ratio Range Unlock SBI Revenue

Dividend Yield Range

SBI Dividend Yield Range Unlock SBI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SBI EPS Forecasts Unlock SBI Revenue
Profile Summary

SourceBio International plc, formerly Sourcebio International Ltd, is a United Kingdom-based provider of integrated laboratory services and products. The Company's businesses include Healthcare Diagnostics, Genomics, Stability Storage and Infectious Disease Testing. Healthcare Diagnostics business include histopathology and clinical diagnostic services for the national health service (NHS) and private healthcare providers. Genomics business offers sanger and next generation sequencing services for pharmaceutical and biotechnology industries, academia, contract research organization (CRO) and other research groups. Stability Storage business offers controlled environmental storage and shelf life testing services and stability storage equipment for pharmaceutical and biotechnology industry, contract manufacturers and analytical testing companies. Infectious Disease Testing business offers antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
No. of Shareholders: n/a
No. of Employees: 223
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange London Stock Exchange (AIM)
Shares in Issue 74,183,038
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SBI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SBI
Upcoming Events for SBI
Frequently Asked Questions for Sourcebio International
What is the Sourcebio International share price?

As of 1:44pm, shares in Sourcebio International are trading at 188p, giving the company a market capitalisation of £140.9m. This share price information is delayed by 15 minutes.

How has the Sourcebio International share price performed this year?

Shares in Sourcebio International are currently trading at 188p and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sourcebio International price has moved by % over the past year.

What are the analyst and broker recommendations for Sourcebio International?

There are no analysts currently covering Sourcebio International.

When will Sourcebio International next release its financial results?

Sourcebio International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Sourcebio International dividend yield?

Sourcebio International does not currently pay a dividend.

Does Sourcebio International pay a dividend?

Sourcebio International does not currently pay a dividend.

When does Sourcebio International next pay dividends?

Sourcebio International does not currently pay a dividend.

How do I buy Sourcebio International shares?

To buy shares in Sourcebio International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sourcebio International?

Shares in Sourcebio International are currently trading at 188p, giving the company a market capitalisation of £140.9m.

Where are Sourcebio International shares listed? Where are Sourcebio International shares listed?

Here are the trading details for Sourcebio International:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SBI
What kind of share is Sourcebio International?

Based on an overall assessment of its quality, value and momentum, Sourcebio International is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sourcebio International share price forecast 2021?

We were not able to load any forecast data for Sourcebio International.

How can I tell whether the Sourcebio International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sourcebio International. Over the past six months, the relative strength of its shares against the market has been %. At the current price of 188p, shares in Sourcebio International are trading at -1.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sourcebio International PE Ratio?

We were not able to find PE ratio data for Sourcebio International.

Who are the key directors of Sourcebio International?

We were unable to find the directors for Sourcebio International.

Who are the major shareholders of Sourcebio International?

Here are the top five shareholders of Sourcebio International based on the size of their shareholding:

Harwood Capital LLP Investment Advisor
Percentage owned: 29.21% (21.7m shares)
Continental Investment Partners SA Investment Advisor
Percentage owned: 22.72% (16.9m shares)
Lombard Odier Asset Management (USA) Corp. Investment Advisor/Hedge Fund
Percentage owned: 21.41% (15.9m shares)
Griffiths (Richard Ian) Individual Investor
Percentage owned: 4.22% (3.13m shares)
Killik & Co Investment Advisor
Percentage owned: 3.03% (2.25m shares)
Similar to SBI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.